NO20032582D0 - 1,2,4-oksadiazolderivater som HPPAR alfa agonister - Google Patents

1,2,4-oksadiazolderivater som HPPAR alfa agonister

Info

Publication number
NO20032582D0
NO20032582D0 NO20032582A NO20032582A NO20032582D0 NO 20032582 D0 NO20032582 D0 NO 20032582D0 NO 20032582 A NO20032582 A NO 20032582A NO 20032582 A NO20032582 A NO 20032582A NO 20032582 D0 NO20032582 D0 NO 20032582D0
Authority
NO
Norway
Prior art keywords
oxadiazole derivatives
alpha agonists
hppar alpha
hppar
agonists
Prior art date
Application number
NO20032582A
Other languages
English (en)
Other versions
NO20032582L (no
Inventor
Francoise Jeanne Gellibert
Kevin Guangcheng Liu
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20032582D0 publication Critical patent/NO20032582D0/no
Publication of NO20032582L publication Critical patent/NO20032582L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20032582A 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister NO20032582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029974.3A GB0029974D0 (en) 2000-12-08 2000-12-08 Chemical compounds
PCT/GB2001/005400 WO2002046174A1 (en) 2000-12-08 2001-12-06 1, 2, 4-oxadiazole derivatives as hppar alpha agonists

Publications (2)

Publication Number Publication Date
NO20032582D0 true NO20032582D0 (no) 2003-06-06
NO20032582L NO20032582L (no) 2003-08-07

Family

ID=9904715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032582A NO20032582L (no) 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister

Country Status (13)

Country Link
US (1) US7141591B2 (no)
EP (1) EP1355890A1 (no)
AU (2) AU2002220902B2 (no)
CA (1) CA2430847A1 (no)
CZ (1) CZ20031581A3 (no)
GB (1) GB0029974D0 (no)
IL (2) IL156174A0 (no)
MX (1) MXPA03005008A (no)
NO (1) NO20032582L (no)
NZ (1) NZ526251A (no)
PL (1) PL360974A1 (no)
WO (1) WO2002046174A1 (no)
ZA (1) ZA200304312B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043997A1 (en) * 2001-11-15 2003-05-30 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
GB0214139D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
MXPA05000279A (es) * 2002-07-09 2005-03-31 Squibb Bristol Myers Co Derivados heterociclicos sustituidos utiles como agentes antidiabeticos y antiobesidad y metodo.
JP2007515484A (ja) 2003-12-22 2007-06-14 イーライ リリー アンド カンパニー トリアゾール、オキサジアゾール、及びチアジアゾール誘導体のｐｐａｒ修飾物質
RS53965B1 (en) * 2010-10-14 2015-08-31 Daiichi Sankyo Company Limited ACILBENZENA DERIVATIVES
KR20140051912A (ko) * 2011-07-29 2014-05-02 다이이찌 산쿄 가부시키가이샤 Ｎ-헤테로 고리 치환 아미드 유도체
BR112014017656A2 (pt) * 2012-01-18 2017-06-27 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso de um composto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960096B1 (en) * 1997-01-22 2005-04-06 Aventis Pharmaceuticals Inc. Substituted beta-thiocarboxylic acids
ES2261202T3 (es) * 1999-04-28 2006-11-16 Sanofi-Aventis Deutschland Gmbh Derivados de acido de triarilo como ligandos para el receptor ppar.
CA2382966A1 (en) * 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation

Also Published As

Publication number Publication date
CZ20031581A3 (cs) 2003-08-13
AU2002220902B2 (en) 2005-06-02
GB0029974D0 (en) 2001-01-24
US7141591B2 (en) 2006-11-28
AU2090202A (en) 2002-06-18
MXPA03005008A (es) 2003-09-05
EP1355890A1 (en) 2003-10-29
NO20032582L (no) 2003-08-07
IL156174A0 (en) 2003-12-23
CA2430847A1 (en) 2002-06-13
ZA200304312B (en) 2004-10-13
US20040132787A1 (en) 2004-07-08
PL360974A1 (en) 2004-09-20
IL156174A (en) 2008-11-03
WO2002046174A1 (en) 2002-06-13
NZ526251A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
NO20030929D0 (no) Guanidinobenzamider som MC4-R agonister
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1244642T3 (da) Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
FR14C0066I2 (fr) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
NO20042372L (no) Nye 1,2,4-tiadiazolderivater som melanokortinreseptormodulatorer
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
DK1442030T3 (da) Thiopen- og thiazolsulfonamider som antineoplastiske midler
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
NO20015668D0 (no) Substituerte imidazotiazoler som antidepressive midler
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20041455L (no) Zirkonium-/metalloksidfibrer.
NO20033700L (no) Isoksazolinderivater som anti-depressive midler
NO20032582D0 (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1532141T3 (da) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazol-derivater og anvendelse deraf som antidepressiv
DE60315471D1 (de) 2,5-disubstituierte 3-mercaptopentansaure
DE60140939D1 (de) Nd darin verwendete zusammensetzung
NO20031239D0 (no) 1-amino-alkylsykloheksaner som trypanocidale midler
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
RU2000116332A (ru) Антгельминтное средство

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application